Type B insulin resistance developing during interferon-α therapy

Endocrine Practice

Volumn 15, Issue 2, 2009, Pages 153-157

  Daniel, Amanda L ^a   Houlihan, Josetta L ^b   Blum, Janice S ^b   Walsh, James P ^a,c  

^a Division of Endocrinology and Metabolism

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AUTOANTIBODY; ERYTHROPOIETIN; INSULIN; INSULIN RECEPTOR ANTIBODY; PEGINTERFERON ALPHA2A; PREDNISONE; RIBAVIRIN; ALPHA INTERFERON; INSULIN RECEPTOR;

ADULT; ANEMIA; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CASE REPORT; CLINICAL FEATURE; CRANIAL NEUROPATHY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; HEPATITIS C; HUMAN; HYPERGLYCEMIA; INSULIN INFUSION; INSULIN RESISTANCE; MALE; SIDE EFFECT; WEAKNESS; WEIGHT REDUCTION; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; IMMUNOPRECIPITATION; MIDDLE AGED; PHYSIOLOGY; REVIEW;

AUTOANTIBODIES; HEPATITIS C; HUMANS; HYPERGLYCEMIA; IMMUNOPRECIPITATION; INSULIN RESISTANCE; INTERFERON-ALPHA; MALE; MIDDLE AGED; RECEPTOR, INSULIN; RIBAVIRIN;

EID: 67549093932     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.15.2.153     Document Type: Article

References (27)

1. Flier JS, Kahn CR, Roth J, Bar RS. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science. 1975;190: 63-65.
2. Arioglu E, Andewelt A, Diabo C, Bell M, Taylor SI, Gorden P. Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective. Medicine (Baltimore). 2002;81:87-100.
3. Khokher MA, Avasthy N, Taylor AM, Fonseca VA, Dandona P. Insulin-receptor antibody and hypoglycaemia associated with Hodgkin's disease. Lancet. 1987;1:693-694.
4. Walters EG, Tavaré JM, Denton RM, Walters G. Hypoglycaemia due to an insulin-receptor antibody in Hodgkin's disease. Lancet. 1987;1:241-243.
5. Rochet N, Blanche S, Carel JC, et al. Hypoglycaemia induced by antibodies to insulin receptor following a bone marrow transplantation in an immunodeficient child. Diabetologia. 1989;32:167-172.
6. Fareau GG, Maldonado M, Oral E, Balasubramanyam A. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome. Metabolism. 2007;56:670-675.
7. Yamauchi K, Pessin JE. Enhancement or inhibition ofinsulin signaling by insulin receptor substrate 1 is cell context dependent. Mol Cell Biol. 1994;14:4427-4434.
8. Boniface JS, Dell'Angelica EC, Springer TA. Immunoprecipitation. In: Ausubel FM, Brent R, Kingston RE, et al, eds. Current Protocols in Molecular Biology. Somerset, NJ: John Wiley & Sons, Inc., 1999: 10.16.1-10.16.29.
9. Gallagher S, Winston SE, Fuller SA, Hurrell JG. Immunoblotting and immunodetection. In: Ausubel FM, Brent R, Kingston RE, et al, eds. Current Protocols in Molecular Biology. Somerset, NJ: John Wiley & Sons, Inc., 2004: 10.16.1-10.16.29.
10. Borg FA, Isenberg DA. Syndromes and complications of interferon therapy. Curr Opin Rheumatol. 2007;19:61-66.
11. Prummel MF, Laurberg P. Interferon-alpha and autoimmune thyroid disease. Thyroid. 2003;6:547-551.
12. Mandac JC, Chaudhry S, Sherman KE, Tomer Y. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology. 2006;43:661-672.
13. Fabris P, Floreani A, Tositti G, Vergani D, de Lalla F, Betterle C. Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Ailment Pharmacol Ther. 2003;18:549-558.
14. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology. 2002;36(5, suppl 1):S237-S244.
15. Lecube A, Hernández C, Genescà J, Simó R.Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study. Diabetes Care. 2006;29:1096-1101.
16. Simó R, Lecube A, Genescà J, Esteban JI, Hernández C. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection. Diabetes Care. 2006; 29:2462-2466.
17. Uto H, Matsuoka H, Murata M, et al. A case of chronic hepatitis C developing insulin-dependent diabetes mellitus associated with various autoantibodies during interferon therapy. Diabetes Res Clin Pract. 2000;49:101-106.
18. Chatterjee S. Massive increase of insulin resistance in a patient with chronic hepatitis C after treatment with interferon. J Assoc Physicians India. 2004;52:514.
19. Bao S, Root C, Jagasia S. Type B insulin resistance syndrome associated with systemic lupus erythematosus. Endocr Pract. 2007;13:51-55.
20. Rosenstein ED, Advani S, Reitz RE, Kramer N. The prevalence of insulin receptor antibodies in patients with systemic lupus erythematosus and related conditions. J Clin Rheumatol. 2001;7:371-373.
21. Servioli L, Pérez C, Consani S, et al. Prevalence and characteristics of immunomediated neuropathies in a group of patients with autoimmune diseases. J Clin Neuromuscul Dis. 2007;9:285-290.
22. Hwang I, Calvit TB, Cash BD, Holtzmuller KC. Bell's palsy: a rare complication of interferon therapy for hepatitis C. Dig Dis Sci. 2004;49:619-620.
23. Hoare M, Woodall T, Alexander GJ. Bell's palsy associated with IFN-alpha and ribavirin therapy for hepatitis C virus infection. J Interferon Cytokine Res. 2005;25:174-176.
24. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27: 1458-1486.
25. Coll AP, Thomas S, Mufti GJ. Rituximab therapy for the type B syndrome of severe insulin resistance. N Engl J Med. 2004;350:310-311.
26. Page KA, Dejardin S, Kahn CR, Kulkarni RN, Herold, KC, Inzucchi SE. A patient with type B insulin resistance syndrome, responsive to immune therapy. Nat Clin Pract Endocrinol Metab. 2007;3:835-840.
27. Eriksson JW, Bremell T, Eliasson B, Fowelin J, Fredriksson L, Yu ZW. Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporine A in type B syndrome of insulin resistance: case report. Diabetes Care. 1998;21:1217-1220.